Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Glia. 2022 Mar 17;70(8):1554–1580. doi: 10.1002/glia.24168

TABLE 3.

Genetic approaches for astrocyte targeting

Approach Concept Properties References
Split-Cre
  • The open reading frame (ORF) of Cre is divided into two parts

  • Each part is expressed by a different promoter

  • Compatible with all LoxP-flanked alleles

  • Enables cell-type-specific labeling (e.g., with standard reporter alleles), knockout, and analyses (e.g., using RiboTag mice)

Beckervordersandforth et al., 2010; Hirrlinger et al., 2019; Hirrlinger, Scheller, et al., 2009; Jullien et al., 2003; Kim, Kolesnikov, et al., 2021
Split-Cre-ERT2
  • Tamoxifen inducible version of Split-Cre

  • Temporal control of Split-Cre mediated recombination

Hirrlinger et al., 2019; Hirrlinger, Requardt, et al., 2009
Split-Cre-Intein
  • Intein mediated interaction of Cre parts

  • High-recombination efficiency

  • Works with three promoters (“SpaRCLIN”)

Luan et al., 2020; Salwig et al., 2019; Wang et al., 2012
Combination of different DNA recombinases (e.g., Cre, Dre, Flp)
  • Each recombinase is driven by a different promoter

  • Use of full-length recombinases

  • Special reporter alleles necessary

  • Allows cell type targeting by the consecutive activity of promoters or Boolean logic (e.g., promoter 1 active, but not promoter 2)

Jensen & Dymecki, 2014; Liu et al., 2020; Madisen et al., 2015
Light-activated DNA recombinases
  • Light-induced dimerization of split-DNA recombinases

  • Precise control of DNA recombination in space and time through light application

Weinberg et al., 2019; Yao et al., 2020
Combination of DNA recombinases and the Tet-system
  • Two promoters driving Cre and tTA

  • Combinatorial targeting by Cre and tTA

  • Temporal control by doxycycline application

Ahmadzadeh et al., 2020; Madisen et al., 2015; Rosellό-Díez et al., 2018